compound semaglutide legal FDA issues warning about some compounded versions of for diabetes, weight loss Safe use of compounded GLP

Glaser KB, Staver MJ, Waring JF, Stender J, Ulrich RG, Davidsen SK

Retatrutide is still completing its phase 3 trial program, with FDA approval estimated for 2027 or 2028

No large-scale RCTs have definitively established sermorelin's efficacy for healthy aging in non-GH-deficient populations

"We want to find ways to improve your health in the safest ways possible." For some peptides, side effects are unknown With insulin, one of the main side effects is low blood sugar while with GLP1s, there's a risk of gastrointestinal issues

doi: 10.1021/acsomega.3c05425 221 Al-GhulikahHAEl-SebaeySABassAKAEl-ZoghbiMS

The alcohol wipe reduces microbial load before you breach the stopper with a needle